Jingyong Huang

A common East-Asian ALDH2 mutation causes metabolic disorders and the therapeutic effect of ALDH2 activators

Yi‐Cheng Chang, Hsiao-Lin Lee, Wenjin Yang et al. · Nature Communications · 2023 · 45 citations · Full text

Life Sciences, Biochemistry, Genetics +17

S824 A PHASE 3 RANDOMIZED, OPEN‐LABEL, MULTICENTER STUDY OF ISATUXIMAB, POMALIDOMIDE, AND LOW‐DOSE DEXAMETHASONE VS POMALIDOMIDE AND LOW‐DOSE DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)

Michel Attal, Paul G. Richardson, S. Vincent Rajkumar et al. · HemaSphere · 2019 · 31 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Expression and significance of FOXP1, HIF-1a and VEGF in renal clear cell carcinoma.

Li Wan, Jingyong Huang, Jianou Chen et al. · PubMed · 2015 · 25 citations

Medicine, Oncology, Pathology +17

The psoas muscle density as a predictor of postoperative complications and 30-day mortality for acute mesenteric ischemia patients

Shouliang Miao, Xiaoning Ye, Tingting Lin et al. · Abdominal Radiology · 2020 · 19 citations

Medicine, Perioperative Medicine, Surgery +9

A Novel ALDH2 Activator AD-9308 Improves Diastolic and Systolic Myocardial Functions in Streptozotocin-Induced Diabetic Mice

Hsiao-Lin Lee, Siow‐Wey Hee, Chin‐Feng Hsuan et al. · Antioxidants · 2021 · 17 citations · Full text

Life Sciences, Cardiology, Pharmacology +17